Difference of bone mineral density between postmenopausal women with and without metabolic syndrome

Not Applicable

Recruiting

• Conditions: postmenopausal womenmetabolic syndrome; postmenopausal; metabolic syndrome

• Registration Number: TCTR20160411002
• Lead Sponsor: Khon Kaen University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-04-11
• Study Completion: 2016-04-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 250

Inclusion Criteria

Postmenopausal women who agreed to include in the study
Age between 45 and 65 years
More than 1 year since her last period
Menopause at ≥ 45 years old by natural or surgical menopause
Diagnosed metabolic syndrome, according to the National Cholesterol Education Program, Adult Treatment Panel III (NCEP ATP III) : ≥ 3 / 5 (Abdominal obesity [≥ 80 cm for women; criteria for Asian population], Hypertriglyceridemia [≥ 150 mg/dL], Low HDL cholesterol [< 50 mg/dL], Hypertension [BP > 130/ 85 mmHg or use of antihypertensive agent], High fasting glucose [≥ 100 mg/dL] or use of hypoglycemic agents

Exclusion Criteria

Taking hormone replacement therapy > 6 months
Taking medication for osteoporosis
Taking steroid more than 3 months
Rheumatoid arthritis
Thyroid disease or thyroid functional abnormality
Malignancy, ESRD, immune deficiency, cardiovascular failure
Cerebrovascular disease/ dementia
Psychiatric disease
Difficult to communicate due to disability

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
bone mineral density of postmenopausal women who had MS and non-MS at the time of recruitment DXA scan

Secondary Outcome Measures

Name	Time	Method
the association of each components of MS and BMD at analysis Multiple linear regression